|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication November 29, 2005.
Revised January 5, 2006.
Accepted for publication January 10, 2006.
3,5-bis(trifluoromethyl)pyrazole derivative (BTP2 or YM-58483) is an immunosuppressive compound that potently inhibits both Ca2+ influx and IL-2 production in lymphocytes. We here report that BTP2 dose-dependently enhances TRPM4, a Ca2+-Activated Nonselective (CAN) cation channel, which decreases Ca2+ influx by depolarizing lymphocytes. The effect of BTP2 on TRPM4 occurs at low nanomolar concentrations and is highly specific, since other ion channels in T lymphocytes are not significantly affected and the major Ca2+ influx pathway in lymphocytes, ICRAC, is blocked only at 100-fold higher concentrations. The efficacy of BTP2 to block IL-2 production is reduced about 100-fold when preventing TRPM4-mediated membrane depolarization, suggesting that the BTP2-mediated facilitation of TRPM4 channels represents the major mechanism for its immunosuppressive effect. Our results demonstrate that TRPM4 channels represent a previously unrecognized key element in lymphocyte Ca2+ signaling and that their facilitation by BTP2 supports cell membrane depolarization, which reduces the driving force for Ca2+ entry and ultimately causes the potent suppression of cytokine release.
Key words:
Ion channel regulation, Calcium (G Protein Coupled Signals)
This article has been cited by other articles:
![]() |
N. Steinckwich, J.-P. Frippiat, M.-J. Stasia, M. Erard, R. Boxio, C. Tankosic, I. Doignon, and O. Nusse Potent inhibition of store-operated Ca2+ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2 J. Leukoc. Biol., April 1, 2007; 81(4): 1054 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF] |
||||